Results 251 to 260 of about 3,916,339 (374)

Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Psychological bulletin, 2013
Hannah R. Snyder
semanticscholar   +1 more source

Gut Bacteria Improve Depressive Symptoms by Degrading Cortisol into Androgen

Advanced Science, EarlyView.
Chronic stress is an important risk factor for stress‐related disorders such as depression. Stress hormone cortisol is essential for the pathogenesis of stress‐related disorders such as depression. Some gut microbiota degraded cortisol, and improve depressive symptoms.
Xiong Wang, Qing Wu, Hao‐Long Zeng, Yin Shen, Hong‐Han Zhang, Jun Gong, Qi Zhang, Jia‐Zhao Xie, Da‐Wei Ye, Zi‐Yong Sun, Zhong‐Chun Liu, Li‐Ming Cheng, Di Li   +12 more
wiley   +1 more source

Sexual minority youth and depressive symptoms or depressive disorder: A systematic review and meta-analysis of population-based studies

Australian and New Zealand journal of psychiatry (Print), 2017
Mathijs F. G. Lucassen, K. Stasiak, Rajvinder Samra, C. Frampton, S. Merry   +4 more
semanticscholar   +1 more source

Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD

Advanced Science, EarlyView.
The ultra‐short‐acting sedative remimazolam has a sustained therapeutic effect on the core symptoms of VPA‐exposed mice. Remimazolam, a GABA agonist, exerts its therapeutic effects by protecting dopamine neurons in the VTA of VPA‐exposed mice. Meanwhile, ferroptosis is the critical mechanism by which remimazolam protects VTA dopaminergic neurons and ...
Yuxin Zhang, Jianwei Lin, Chaoyang Tong, Xin Fu, Mengqin Shan, Yue Huang, Kan Zhang, Jijian Zheng   +7 more
wiley   +1 more source

Pharmacogenetics and the Response to Antidepressants in Major Depressive Disorder. [PDF]

Pharmaceuticals (Basel)
Bertollo AG, Mocelin R, Ignácio ZM.
europepmc   +1 more source

Incident and recurrent major depressive disorder and coronary artery disease severity in acute coronary syndrome patients

, 2007
Jeanne Goodman, Daichi Shimbo, Donald Haas, Karina W. Davidson, Nina Rieckmann   +4 more
openalex   +1 more source

Taurocholic Acid Is Associated With Disturbed Functional Connectivity in the Hippocampus of Patients With Depression

Advanced Science, EarlyView.
This study identifies elevated taurocholic acid (TCA) in Major Depressive Disorder patients. Gut microbiome‐associated TCA impairs hippocampal neurogenesis, triggers microglia activation, and elicits depression‐like behavior in mice via the S1PR2. In patients, functional neuroimaging reveals that serum TCA levels correlate with altered functional ...
Xiaoying Cai, Taipeng Sun, Mengzhen Feng, Gang Chen, Junchi Zhou, Hong Zhuang, Dan Wang, Ying Chen, Zhen Cheng, Zhi Xu, Xiao Zheng, Xueli Zhang, Yonggui Yuan   +12 more
wiley   +1 more source

Microglial Activation in Cerebrovascular Accidents and the Manifestation of Major Depressive Disorder: A Comprehensive Review. [PDF]

Brain Sci
Razón-Hernández KC, Martínez-Ramírez G, Villafranco J, Rodríguez-Barreto O, Ortuño-Sahagun D, Magaña-Maldonado R, Sánchez-Huerta K, Becerril-Villanueva E, Pavón L, Estudillo E, Pérez-Sánchez G.   +10 more
europepmc   +1 more source

Driven by rewards or punishments? Understanding real world social functioning in anxiety and depressive disorders

Alan M. Gross, Madeleine Rassaby, Susie Adams, Colin A. Depp, Raeanne C Moore, Charles T. Taylor   +5 more
openalex   +1 more source

<p>Efficacy of Eye Movement Desensitization and Reprocessing on the Quality of Life in Patients with Major Depressive Disorder: A Randomized Clinical Trial</p>

, 2020
Abdolhadi Jahanfar, Zhila Fereidouni, Mohammad Behnammoghadam, Azizallah Dehghan, Somayeh Bashti   +4 more
openalex   +2 more sources